Enzomenib 1 mg | ≥98% Cayman Chemical An inhibitor of the menin-MLL1 protein-protein interaction More Information Supplier Page × Enzomenib
GalNAc Tri-CBz 10 mg | ≥95% Cayman Chemical A derivative of GalNAc More Information Supplier Page × GalNAc Tri-CBz
GalNAc Tri-CBz 25 mg | ≥95% Cayman Chemical A derivative of GalNAc More Information Supplier Page × GalNAc Tri-CBz
BP Lipid 229 50 mg | ≥98% Cayman Chemical An ionizable cationic lipid More Information Supplier Page × BP Lipid 229
BP Lipid 229 10 mg | ≥98% Cayman Chemical An ionizable cationic lipid More Information Supplier Page × BP Lipid 229
BP Lipid 229 25 mg | ≥98% Cayman Chemical An ionizable cationic lipid More Information Supplier Page × BP Lipid 229
BP Lipid 229 5 mg | ≥98% Cayman Chemical An ionizable cationic lipid More Information Supplier Page × BP Lipid 229
Sonrotoclax 25 mg | ≥98% Cayman Chemical A Bcl-2 and Bcl-2G101V inhibitor More Information Supplier Page × Sonrotoclax
Sonrotoclax 5 mg | ≥98% Cayman Chemical A Bcl-2 and Bcl-2G101V inhibitor More Information Supplier Page × Sonrotoclax
Sonrotoclax 10 mg | ≥98% Cayman Chemical A Bcl-2 and Bcl-2G101V inhibitor More Information Supplier Page × Sonrotoclax
